☆ 4.8 Article

Case Report: Gene expression profiling of COVID-19 vaccination-related lymphadenopathies reveals evidence of a dominantly extrafollicular immune response

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Allergy

Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach

Adrian Rodriguez-Ferreras et al.

Summary: Kikuchi-Fujimoto Disease (KFD) is a rare disorder characterized by subacute necrotizing regional lymphadenopathy. It has been found that there is a higher number of KFD cases related to COVID-19 vaccines, highlighting the importance of pharmacovigilance in detecting adverse events caused by new vaccines.

EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Allergy

Patients with coronavirus disease 2019 characterized by dysregulated levels of membrane and soluble cluster of differentiation 48

Hadas Pahima et al.

Summary: CD48 expression in lung tissues and peripheral blood leukocytes of COVID-19 patients was found to be dysregulated, suggesting its potential involvement in disease progression and inflammation. Further investigation is needed to understand the role of CD48 in COVID-19.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2023)

Add to Collection

Article Pathology

Atypical follicular hyperplasia with light chain-restricted germinal centers after COVID-19 booster: a diagnostic pitfall

Ashish Patil et al.

Summary: COVID-19 vaccine can cause lymphadenopathy which may resemble metastasis or cancer recurrence. This case report describes the histopathologic features of persistent lymphadenopathy in a breast cancer patient following a COVID-19 vaccine booster. Although the histological features mimic follicular lymphoma, the findings were ultimately interpreted as a reactive lesion associated with the timing of COVID-19 vaccine administration, rather than true lymphoma.

VIRCHOWS ARCHIV (2023)

Add to Collection

Article Immunology

Evaluation of mortality risk after COVID-19 vaccination, Utah 2021

Jessica R. Payne et al.

Summary: To evaluate trends in death after COVID-19 vaccination, the timing of death relative to vaccination date and causes of death were analyzed. The study found that mortality rates in the 44 weeks following COVID-19 vaccination did not show trends suggesting an increase in mortality related to vaccination, reinforcing the safety of COVID-19 vaccines.

VACCINE (2023)

Add to Collection

Article Immunology

Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination

Tzu-Chuan Ho et al.

Summary: Mass vaccination against COVID-19 has led to frequent reports of vaccine-associated lymphadenopathy, which is influenced by factors such as age, gender, and lymph node reaction. A systematic review of sixty-two articles revealed that days post-vaccination and B cell germinal center response are negatively associated with the incidence of lymphadenopathy. The study suggests that a strong vaccine immune response, possibly mediated by the B cell germinal center response, contributes to the development of lymphadenopathy. Therefore, it is important to differentiate between reactive lymph nodes and metastatic lymph node enlargement, especially in patients with underlying malignancy, through medical history collection or evaluation.

VACCINES (2023)

Add to Collection

Article Hematology

Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies

Jana van den Berg et al.

Summary: In this study, autopsy samples from COVID-19 patients were compared to controls, and it was found that VWF is a key component of COVID-19-related thrombi. It is suggested that VWF may be a potential therapeutic target for severe COVID-19.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Add to Collection

Editorial Material Medicine, General & Internal

Extrafollicular proliferation of B-blasts: Morphologic correlate to Spikevax-induced lymphadenopathy

Alexandar Tzankov et al.

Summary: A 30-year-old male presented with PET-positive left-sided cervical lymphadenopathy, suspected to be metastasis of a known right-sided papillary thyroid cancer. The first dose of Pfizer's Spikevax vaccine administered three weeks ago was not documented or reported to the pathologists. Diagnostic lymphadenectomy revealed extrafollicular proliferation of B-blasts, likely associated with the vaccine administration.

CLINICAL CASE REPORTS (2022)

Add to Collection

Review Medicine, General & Internal

Pathological Findings in COVID-19 and Non-COVID-19 Vaccine-Associated Lymphadenopathy: A Systematic Review

Tzy Harn Chua et al.

Summary: This study described the pathological findings of COVID-19 vaccine-associated lymphadenopathy and non-COVID-19 vaccine-associated lymphadenopathy. Most cases of COVID-19 vaccine-associated lymphadenopathy were diagnosed as reactive or benign, but other diagnoses such as florid lymphoid hyperplasia, Kikuchi-Fujimoto disease, and granulomatous inflammation were also reported. Clinical and radiological correlation is needed for optimal patient management in most cases.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient

Francois R. Girardin et al.

Summary: We report a case of recurrent tender, multifocal lymphadenopathies in an mRNA-1273 vaccine recipient who recently had an Epstein-Barr virus infection. The clinical presentation mimicked lymphoma. Lymph node biopsy revealed monocytoid B-cell hyperplasia, TH2 (GATA3+) predominance, and hyperplasia of interferon-gamma-producing plasmacytoid dendritic cells. Sustained neutralising antibody production against SARS-CoV-2 wild-type and five variants was observed. The patient exhibited high titres of anti-S antibodies and neutralising antibodies, except for variant B.1.529** (omicron) and B.1.351** (beta) due to spike protein mutations. We hypothesize that EBV, in combination with the mRNA-1273 vaccine, induced a prolonged inflammatory response.

SWISS MEDICAL WEEKLY (2022)

Add to Collection

Article Pediatrics

Toll-like receptor 10 rs10004195 variation may be protective against Bacillus Calmette-Guerin osteitis after newborn vaccination

Matti Korppi et al.

Summary: Previous studies found associations between TLR1, TLR2, and TLR6 variations with the risk of BCG osteitis, while this study identified an association between TLR10 rs10004195 polymorphism and the risk of BCG osteitis.

ACTA PAEDIATRICA (2021)

Add to Collection

Article Immunology

Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19

Jasmin D. Haslbauer et al.

Summary: A study on pulmonary draining lymph nodes of COVID-19 cases revealed dysregulated immune responses, including accumulation of extrafollicular plasmablasts, T-cell dysregulation, macrophage activation, and microvascular dysfunction.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Cell Biology

Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

Thomas Menter et al.

HISTOPATHOLOGY (2020)

Add to Collection

Review Immunology

TLR10 and Its Unique Anti-Inflammatory Properties and Potential Use as a Target in Therapeutics

Faith Fore et al.

IMMUNE NETWORK (2020)

Add to Collection

Article Medicine, Research & Experimental

Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response

Darin K. Edwards et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2017)

Add to Collection

Article Oncology

Using lymph node swelling as a potential biomarker for successful vaccination

Kimberly D. Brewer et al.

ONCOTARGET (2016)

Add to Collection

Article Multidisciplinary Sciences

Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling

Su-Chang Lin et al.

NATURE (2010)

Add to Collection

Article Cell Biology

Extrafollicular proliferation of B cells in the absence of follicular hyperplasia:: a distinct reaction pattern in lymph nodes correlated with primary or recall type responses

A Brighenti et al.

HISTOPATHOLOGY (2005)

Add to Collection

Article Biochemistry & Molecular Biology

Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells

TH Chuang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.